In human studies, decreasing blood RBP4 levels by drug therapies improved insulin resistance [3], and a link between RBP4 gene and type 2 diabetes has been found in genetic studies [4, 5]. The gene discussed is RBP4; the disease is type 2 diabetes mellitus.